These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 8458924)
21. Addition of estradiol to progesterone for luteal supplementation in patients stimulated with GnRH antagonist/rFSH for IVF: a randomized controlled trial. Fatemi HM; Kolibianakis EM; Camus M; Tournaye H; Donoso P; Papanikolaou E; Devroey P Hum Reprod; 2006 Oct; 21(10):2628-32. PubMed ID: 16857887 [TBL] [Abstract][Full Text] [Related]
22. The luteal phase after in-vitro fertilization and related procedures. Van Steirteghem AC; Smitz J; Camus M; Van Waesberghe L; Deschacht J; Khan I; Staessen C; Wisanto A; Bourgain C; Devroey P Hum Reprod; 1988 Feb; 3(2):161-4. PubMed ID: 3128572 [TBL] [Abstract][Full Text] [Related]
23. Endocrine responses to gonadotrophins after LHRH agonist administration on cycle days 1-4: prevention of premature luteinization. Martikainen H; Rönnberg L; Tapanainen J; Puistola U; Orava M; Kauppila A Hum Reprod; 1990 Apr; 5(3):246-9. PubMed ID: 2112552 [TBL] [Abstract][Full Text] [Related]
24. Management of failed cycles in an IVF/GIFT programme with the combination of a GnRH analogue and HMG. Smitz J; Devroey P; Braeckmans P; Camus M; Khan I; Staessen C; Van Waesberghe L; Wisanto A; Van Steirteghem AC Hum Reprod; 1987 May; 2(4):309-14. PubMed ID: 3114314 [TBL] [Abstract][Full Text] [Related]
25. GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study. Humaidan P; Bredkjaer HE; Bungum L; Bungum M; Grøndahl ML; Westergaard L; Andersen CY Hum Reprod; 2005 May; 20(5):1213-20. PubMed ID: 15760966 [TBL] [Abstract][Full Text] [Related]
26. Differential effects of gonadotrophin-releasing hormone agonists administered as desensitizing or flare protocols on hormonal function in the luteal phase of hyperstimulated cycles. Norman RJ; Warnes GM; Wang X; Kirby CA; Matthews CD Hum Reprod; 1991 Feb; 6(2):206-13. PubMed ID: 1905309 [TBL] [Abstract][Full Text] [Related]
27. GnRH agonist as luteal phase support in assisted reproduction technique cycles: results of a pilot study. Pirard C; Donnez J; Loumaye E Hum Reprod; 2006 Jul; 21(7):1894-900. PubMed ID: 16556673 [TBL] [Abstract][Full Text] [Related]
28. Comparison of HMG/HCG superovulation for AID with or without superactive GnRH agonist. Gerris J; Jacquemyn Y; Desmedt E; Delbeke L; Buytaert P Hum Reprod; 1989 Nov; 4(8):937-40. PubMed ID: 2515211 [TBL] [Abstract][Full Text] [Related]
29. GnRH agonist (buserelin) or HCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study. Engmann L; Benadiva C Hum Reprod; 2005 Nov; 20(11):3258-60; author reply 3260. PubMed ID: 16246862 [No Abstract] [Full Text] [Related]
30. Addition of Buserelin to human menopausal gonadotrophins in patients with failed stimulations for IVF or GIFT. Smitz J; Devroey P; Camus M; Khan I; Staessen C; Van Waesberghe L; Wisanto A; Van Steirteghem AC Hum Reprod; 1988 Oct; 3 Suppl 2():35-8. PubMed ID: 3147990 [TBL] [Abstract][Full Text] [Related]
31. Inhibition of progesterone secretion by oestradiol administered in the luteal phase of assisted conception cycles. Tay PY; Lenton EA Med J Malaysia; 2003 Jun; 58(2):187-95. PubMed ID: 14569738 [TBL] [Abstract][Full Text] [Related]
32. The effect of human menopausal gonadotrophin and highly purified, urine-derived follicle stimulating hormone on the outcome of in-vitro fertilization in down-regulated normogonadotrophic women. Westergaard LG; Erb K; Laursen S; Rasmussen PE; Rex S Hum Reprod; 1996 Jun; 11(6):1209-13. PubMed ID: 8671425 [TBL] [Abstract][Full Text] [Related]
34. Is continuation of a gonadotrophin-releasing hormone agonist (GnRHa) necessary for women at risk of developing the ovarian hyperstimulation syndrome? Wada I; Matson PL; Horne G; Buck P; Lieberman BA Hum Reprod; 1992 Sep; 7(8):1090-3. PubMed ID: 1400932 [TBL] [Abstract][Full Text] [Related]
35. A prospective randomized single-blind comparative trial of nafarelin acetate with buserelin in long-protocol gonadotrophin-releasing hormone analogue controlled in-vitro fertilization cycles. Lockwood GM; Pinkerton SM; Barlow DH Hum Reprod; 1995 Feb; 10(2):293-8. PubMed ID: 7769051 [TBL] [Abstract][Full Text] [Related]
36. Clinical and endocrinological changes in women following ovulation induction using buserelin acetate/human menopausal gonadotrophin augmented with biosynthetic human growth hormone. Hughes SM; Huang ZH; Matson PL; Buck P; Lieberman BA; Morris ID Hum Reprod; 1992 Jul; 7(6):770-5. PubMed ID: 1500473 [TBL] [Abstract][Full Text] [Related]
37. Trial of support treatment with human chorionic gonadotrophin in the luteal phase after treatment with buserelin and human menopausal gonadotrophin in women taking part in an in vitro fertilisation programme. Smith EM; Anthony FW; Gadd SC; Masson GM BMJ; 1989 Jun; 298(6686):1483-6. PubMed ID: 2503080 [TBL] [Abstract][Full Text] [Related]
38. GnRH agonist. Increasing the pregnancy rate after combined treatment with hMG/hCG and direct intraperitoneal insemination. Minoura H; Takeuchi S; Shen X; Shibahara T; Futamura N; Toyoda N J Reprod Med; 1999 Jan; 44(1):18-22. PubMed ID: 9987734 [TBL] [Abstract][Full Text] [Related]
39. Estradiol/progesterone substitution in the luteal phase improves pregnancy rates in stimulated cycles--but only in younger women. Gleicher N; Brown T; Dudkiewicz A; Karande V; Rao R; Balin M; Campbell D; Pratt D Early Pregnancy (Cherry Hill); 2000 Jan; 4(1):64-73. PubMed ID: 11719823 [TBL] [Abstract][Full Text] [Related]
40. The origin of serum progesterone during the follicular phase of menotropin-stimulated cycles. Eldar-Geva T; Margalioth EJ; Brooks B; Algur N; Zylber-Haran E; Diamant YZ Hum Reprod; 1998 Jan; 13(1):9-14. PubMed ID: 9512220 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]